The global drug transport technology market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for drug delivery systems that are safe and effective in delivering drugs across various routes of administration. The oral route is expected to dominate the global drug transport technology market during the forecast period, due to its high efficacy and safety profile.
The global drug transport technology market by type includes oral, injectable, topical, ocular, nasal, pulmonary and transmucosal technologies. Oral technologies are expected to dominate the global drug transport technology market during the forecast period due to their high efficacy and safety profile. Injectable technologies are also projected to grow at a significant rate during the forecast period owing their ease of use in emergency situations when intravenous access cannot be established or maintained for patients with severe bleeding or shock conditions who need immediate treatment with blood products or fluids containing clotting factors such as Factor VIII or Factor IX concentrates (e.g., Hemophilia A). Topical technologies are projected to witness moderate growth over the next few years owing their ease of use in treating localized skin conditions such as psoriasis and eczema without any systemic side effects on other organs such as liver or kidney damage which may occur with oral medications that have been absorbed into bloodstream through gastrointestinal tract (e.g., methotrexate). Transmucosal devices include buccal tablets/lozenges/strips/powders/sprays; sublingual tablets; sublingual sprays; buccal films; rectal suppositories; vaginal rings; vaginal films; transdermal patches and intranasal sprays among others which can be used for administering drugs across various routes including mouth-to-brain passage via mucosa lining inside cheek cavity called buccinator muscle where it can bypass stomach acidity barrier thus avoiding first pass metabolism effect before reaching brain tissue where it exerts its therapeutic effect while avoiding adverse reactions associated with orally administered drugs like nausea vomiting diarrhea constipation etc; nose-to-brain passage via olfactory bulb located inside skull bone near brain stem where it can bypass stomach acidity barrier thus avoiding first pass metabolism effect before reaching brain tissue where it exerts its therapeutic effect while avoiding adverse reactions associated with orally administered drugs like nausea vomiting diarrhea constipation etc; rectum-to-brain passage via anus muscle called puborectalis muscle located between rectum wall and anal canal opening where it can bypass stomach acidity barrier thus avoiding first pass metabolism effect before reaching brain tissue where it exerts its therapeutic effect while avoiding adverse reactions associated with orally administered Drugs Like Nausea Vomiting Diarrhea Constipation Etc.; vagina -to-brain passage via cervix uteri opening located between uterus wall & vagina opening where it can bypass stomach acidity barrier thus avoid first pass metabolism effect before reaching brain tissue where it exerts its therapeutic effect while preventing adverse reactions associated with orally administered drugs like nausea vomiting diarrhea constipation etc; nose -to-brain passage via olfactory bulb located inside skull bone near brain stem whereby they can bypass stomach acidity barrier thus avoid first pass metabolism affect before reaching brain tissue whereby they exerts its therapeutic affect while preventing adverse reaction associated wth orally adminstered drugs like nausea vomiting diarrhea constipation etc; intranasal passages include nose passages whereby they can bypass stomach acidity barrier thus avoid first pas metabolic affect before reachinng bran tisue wherein they exert thertherapeutic affect whil preventinng adversee reaction associate wth orally adminstered drgs lik nausia vomitin diarrhoea constipatin et cetera.
- Increasing awareness about the benefits of using these products in hospitals and clinics will also drive growth in this market during the forecast period.
- Technological advancements are expected to provide better solutions for drug transportation, which will further fuel growth in this market over the next few years .
Industry Growth Insights published a new data on “Drug Transport Technology Market”. The research report is titled “Drug Transport Technology Market research by Types (Oral, Injectable, Topical, Ocular, Nasal, Pulmonary, Transmucosal, Implantable), By Applications (Hospitals, Ambulatory Surgical Centers, Home Care settings, Diagnostic Centers, Other), By Players/Companies Johnson & Johnson Services, Novartis AG, F. Hoffmann-La Roche, Pfizer, Antares Pharma, BD, Glaxosmithkline, 3M, Merck, Sanofi”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Transport Technology Market Research Report
By Type
Oral, Injectable, Topical, Ocular, Nasal, Pulmonary, Transmucosal, Implantable
By Application
Hospitals, Ambulatory Surgical Centers, Home Care settings, Diagnostic Centers, Other
By Companies
Johnson & Johnson Services, Novartis AG, F. Hoffmann-La Roche, Pfizer, Antares Pharma, BD, Glaxosmithkline, 3M, Merck, Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Drug Transport Technology Market Report Segments:
The global Drug Transport Technology market is segmented on the basis of:
Types
Oral, Injectable, Topical, Ocular, Nasal, Pulmonary, Transmucosal, Implantable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Home Care settings, Diagnostic Centers, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson Services
- Novartis AG
- F. Hoffmann-La Roche
- Pfizer
- Antares Pharma
- BD
- Glaxosmithkline
- 3M
- Merck
- Sanofi
Highlights of The Drug Transport Technology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Injectable
- Topical
- Ocular
- Nasal
- Pulmonary
- Transmucosal
- Implantable
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Home Care settings
- Diagnostic Centers
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Transport Technology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug transport technology is a system that helps to move drugs safely and efficiently from their point of origin to their destination. This system can include everything from specialized vehicles and equipment to advanced security measures.
Some of the major players in the drug transport technology market are Johnson & Johnson Services, Novartis AG, F. Hoffmann-La Roche, Pfizer, Antares Pharma, BD, Glaxosmithkline, 3M, Merck, Sanofi.
The drug transport technology market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Transport Technology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug Transport Technology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug Transport Technology Market - Supply Chain
4.5. Global Drug Transport Technology Market Forecast
4.5.1. Drug Transport Technology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug Transport Technology Market Size (000 Units) and Y-o-Y Growth
4.5.3. Drug Transport Technology Market Absolute $ Opportunity
5. Global Drug Transport Technology Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Drug Transport Technology Market Size and Volume Forecast by Type
5.3.1. Oral
5.3.2. Injectable
5.3.3. Topical
5.3.4. Ocular
5.3.5. Nasal
5.3.6. Pulmonary
5.3.7. Transmucosal
5.3.8. Implantable
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Drug Transport Technology Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Drug Transport Technology Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers
6.3.3. Home Care settings
6.3.4. Diagnostic Centers
6.3.5. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Drug Transport Technology Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Drug Transport Technology Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Drug Transport Technology Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Drug Transport Technology Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Drug Transport Technology Demand Share Forecast, 2019-2026
9. North America Drug Transport Technology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Drug Transport Technology Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Drug Transport Technology Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Centers
9.4.3. Home Care settings
9.4.4. Diagnostic Centers
9.4.5. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Drug Transport Technology Market Size and Volume Forecast by Type
9.7.1. Oral
9.7.2. Injectable
9.7.3. Topical
9.7.4. Ocular
9.7.5. Nasal
9.7.6. Pulmonary
9.7.7. Transmucosal
9.7.8. Implantable
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Drug Transport Technology Demand Share Forecast, 2019-2026
10. Latin America Drug Transport Technology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Drug Transport Technology Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Drug Transport Technology Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Home Care settings
10.4.4. Diagnostic Centers
10.4.5. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Drug Transport Technology Market Size and Volume Forecast by Type
10.7.1. Oral
10.7.2. Injectable
10.7.3. Topical
10.7.4. Ocular
10.7.5. Nasal
10.7.6. Pulmonary
10.7.7. Transmucosal
10.7.8. Implantable
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Drug Transport Technology Demand Share Forecast, 2019-2026
11. Europe Drug Transport Technology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Drug Transport Technology Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Drug Transport Technology Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Home Care settings
11.4.4. Diagnostic Centers
11.4.5. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Drug Transport Technology Market Size and Volume Forecast by Type
11.7.1. Oral
11.7.2. Injectable
1.7.3. Topical
11.7.4. Ocular
11.7.5. Nasal
11.7.6. Pulmonary
11.7.7. Transmucosal
11.7.8. Implantable
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Drug Transport Technology Demand Share, 2019-2026
12. Asia Pacific Drug Transport Technology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Drug Transport Technology Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Drug Transport Technology Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Home Care settings
12.4.4. Diagnostic Centers
12.4.5. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Drug Transport Technology Market Size and Volume Forecast by Type
12.7.1. Oral
12.7.2. Injectable
12.7.3. Topical
12.7.4. Ocular
12.7.5. Nasal
12.7.6. Pulmonary
12.7.7. Transmucosal
12.7.8. Implantable
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Drug Transport Technology Demand Share, 2019-2026
13. Middle East & Africa Drug Transport Technology Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Drug Transport Technology Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Drug Transport Technology Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Home Care settings
13.4.4. Diagnostic Centers
13.4.5. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Drug Transport Technology Market Size and Volume Forecast by Type
13.7.1. Oral
13.7.2. Injectable
13.7.3. Topical
13.7.4. Ocular
13.7.5. Nasal
13.7.6. Pulmonary
13.7.7. Transmucosal
13.7.8. Implantable
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Drug Transport Technology Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Drug Transport Technology Market: Market Share Analysis
14.2. Drug Transport Technology Distributors and Customers
14.3. Drug Transport Technology Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Johnson & Johnson Services
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Novartis AG
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. F. Hoffmann-La Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Pfizer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Antares Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. BD
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Glaxosmithkline
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. 3M
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Merck
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sanofi
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
